Zebrafish Models: From Basic Research to Translational Medicine
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 67
Special Issue Editors
Interests: zebrafish model organism in health prevention, preservation, and treatment; zebrafish transparent transgenic cellular phenotype development and applications; experimental therapeutics; high throughput drug discovery; identification of hit and lead drugs; repurposing of FDA-approved drugs in disease treatment and prevention; genomics; tumor microenvironment; pharmacogenomics; drug-induced toxicity; glioblastoma; microglia pathophysiology; cancer drug-induced cardiotoxicity
Interests: interventional cardiology; preventative cardiology; cardiovascular thromboinflammatory pathways; coronary microvascular dysfunction; zebrafish cardiovascular disease models; drug-induced cardiotoxicity; vascular biology; pulmonary embolism and venous thromboembolism; mechanical thrombectomy; endovascular interventions
Special Issue Information
Dear Colleagues,
Zebrafish have emerged as a powerful model organism in biomedical research, bridging the gap between basic science and clinical applications. With its high genetic homology to humans, rapid development, transparency, and suitability for high-throughput screening, the zebrafish model offers unique advantages for studying developmental biology, disease mechanisms, drug discovery, and toxicology. In recent decades, zebrafish have made significant contributions to breakthroughs in cancer research, neurobiology, cardiovascular disease, and regenerative medicine.
This Special Issue aims to collate innovative research that demonstrates the utility of zebrafish models in advancing our understanding of human diseases and therapeutic development. The scope of this Special Issue aligns with the journal’s focus on experimental and translational biology, covering molecular mechanisms, disease modeling, drug screening, and biomedical applications. For this Special Issue, original research articles and reviews are welcome to be submitted.
We look forward to receiving your contributions and collaborating with you to advance the field of zebrafish biomedical research.
Dr. Surendra Rajpurohit
Prof. Dr. Vishal Arora
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- zebrafish
- animal models
- in vivo whole model organism imaging
- epigenetics
- physiological and functional discoveries
- genetic engineered transgenic cellular and mutant phenotype
- developmental biology
- drug discovery
- high-throughput drug screening
- pharmacogenomics
- translational research
- toxicology
- genomics
- cardiology
- cardio-oncology
- cardiovascular diseases
- cardio-oncology
- cancer models
- melanoma
- tumor microenvironment
- dermatology
- ophthalmology
- neuroscience
- aging
- neurodegenerative disease
- diabetes
- kidney disease
- hematology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
